In AD, the overactivity and/or overexpression of GSK-3β accounts for memory impairment, tau hyperphosphorylation, increased β-amyloid production, and local plaque-associated microglial-mediated inflammatory responses, which are hallmarks of the disease [40]. Here, MAPT is linked to Alzheimer disease.